Shin Nippon Biomedical Laboratories, Ltd. (2395.T)
JPY 1537.0
(-1.22%)
JPY 1537.0
(-1.22%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 26.33 Billion JPY | 40.35% |
| 2022 | 18.76 Billion JPY | 105.3% |
| 2021 | 9.13 Billion JPY | -27.97% |
| 2020 | 12.68 Billion JPY | -14.99% |
| 2019 | 14.92 Billion JPY | -6.45% |
| 2018 | 15.95 Billion JPY | -15.75% |
| 2017 | 18.93 Billion JPY | -17.35% |
| 2016 | 22.9 Billion JPY | 2.62% |
| 2015 | 22.32 Billion JPY | 0.56% |
| 2014 | 22.19 Billion JPY | 2.28% |
| 2013 | 21.7 Billion JPY | -4.48% |
| 2012 | 22.71 Billion JPY | 5.34% |
| 2011 | 21.56 Billion JPY | -1.13% |
| 2010 | 21.81 Billion JPY | -0.79% |
| 2009 | 21.98 Billion JPY | 10.72% |
| 2008 | 19.85 Billion JPY | 44.1% |
| 2007 | 13.78 Billion JPY | 8.8% |
| 2006 | 12.66 Billion JPY | 49.94% |
| 2005 | 8.44 Billion JPY | -14.94% |
| 2004 | 9.93 Billion JPY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 33.34 Billion JPY | 26.66% |
| 2023 Q4 | 26.33 Billion JPY | -1.34% |
| 2023 Q2 | 22.14 Billion JPY | -2.24% |
| 2023 Q1 | 22.65 Billion JPY | 20.75% |
| 2023 Q3 | 26.68 Billion JPY | 20.5% |
| 2023 FY | 26.33 Billion JPY | 40.35% |
| 2022 Q3 | 16.86 Billion JPY | -8.14% |
| 2022 Q2 | 18.35 Billion JPY | 41.29% |
| 2022 Q1 | 12.99 Billion JPY | 42.16% |
| 2022 FY | 18.76 Billion JPY | 105.3% |
| 2022 Q4 | 18.76 Billion JPY | 11.27% |
| 2021 Q4 | 9.13 Billion JPY | -10.22% |
| 2021 Q2 | 10.62 Billion JPY | -10.58% |
| 2021 Q1 | 11.88 Billion JPY | -6.29% |
| 2021 FY | 9.13 Billion JPY | -27.97% |
| 2021 Q3 | 10.17 Billion JPY | -4.25% |
| 2020 Q3 | 14.04 Billion JPY | -4.23% |
| 2020 Q1 | 16.3 Billion JPY | 9.24% |
| 2020 Q2 | 14.66 Billion JPY | -10.03% |
| 2020 FY | 12.68 Billion JPY | -14.99% |
| 2020 Q4 | 12.68 Billion JPY | -9.69% |
| 2019 Q3 | 14.84 Billion JPY | -0.39% |
| 2019 FY | 14.92 Billion JPY | -6.45% |
| 2019 Q1 | 15.47 Billion JPY | -2.98% |
| 2019 Q2 | 14.89 Billion JPY | -3.72% |
| 2019 Q4 | 14.92 Billion JPY | 0.55% |
| 2018 FY | 15.95 Billion JPY | -15.75% |
| 2018 Q3 | 16.68 Billion JPY | -11.91% |
| 2018 Q2 | 18.93 Billion JPY | 2.48% |
| 2018 Q1 | 18.47 Billion JPY | -2.4% |
| 2018 Q4 | 15.95 Billion JPY | -4.38% |
| 2017 Q4 | 18.93 Billion JPY | -2.95% |
| 2017 Q3 | 19.5 Billion JPY | -1.13% |
| 2017 Q2 | 19.73 Billion JPY | -2.89% |
| 2017 Q1 | 20.31 Billion JPY | -11.3% |
| 2017 FY | 18.93 Billion JPY | -17.35% |
| 2016 Q1 | 21.68 Billion JPY | -2.84% |
| 2016 Q2 | 23.58 Billion JPY | 8.77% |
| 2016 FY | 22.9 Billion JPY | 2.62% |
| 2016 Q4 | 22.9 Billion JPY | 0.3% |
| 2016 Q3 | 22.83 Billion JPY | -3.18% |
| 2015 Q1 | 19.14 Billion JPY | -13.73% |
| 2015 Q3 | 20.66 Billion JPY | -7.54% |
| 2015 Q2 | 22.34 Billion JPY | 16.68% |
| 2015 FY | 22.32 Billion JPY | 0.56% |
| 2015 Q4 | 22.32 Billion JPY | 8.03% |
| 2014 Q3 | 21.3 Billion JPY | -4.35% |
| 2014 FY | 22.19 Billion JPY | 2.28% |
| 2014 Q4 | 22.19 Billion JPY | 4.18% |
| 2014 Q1 | 19.77 Billion JPY | -8.86% |
| 2014 Q2 | 22.27 Billion JPY | 12.62% |
| 2013 Q3 | 23.02 Billion JPY | -5.28% |
| 2013 Q2 | 24.3 Billion JPY | 11.53% |
| 2013 Q1 | 21.79 Billion JPY | -4.08% |
| 2013 FY | 21.7 Billion JPY | -4.48% |
| 2013 Q4 | 21.7 Billion JPY | -5.73% |
| 2012 Q1 | 20.37 Billion JPY | -5.53% |
| 2012 Q4 | 22.71 Billion JPY | -3.06% |
| 2012 Q3 | 23.43 Billion JPY | -4.88% |
| 2012 Q2 | 24.64 Billion JPY | 20.94% |
| 2012 FY | 22.71 Billion JPY | 5.34% |
| 2011 Q4 | 21.56 Billion JPY | -4.45% |
| 2011 Q3 | 22.57 Billion JPY | 1.39% |
| 2011 Q2 | 22.26 Billion JPY | 7.41% |
| 2011 Q1 | 20.72 Billion JPY | -4.99% |
| 2011 FY | 21.56 Billion JPY | -1.13% |
| 2010 FY | 21.81 Billion JPY | -0.79% |
| 2010 Q1 | 21.05 Billion JPY | -4.23% |
| 2010 Q2 | 24.01 Billion JPY | 14.03% |
| 2010 Q3 | 23.73 Billion JPY | -1.15% |
| 2010 Q4 | 21.81 Billion JPY | -8.1% |
| 2009 Q4 | 21.98 Billion JPY | -4.83% |
| 2009 FY | 21.98 Billion JPY | 10.72% |
| 2009 Q3 | 23.1 Billion JPY | 17.68% |
| 2009 Q2 | 19.63 Billion JPY | 0.0% |
| 2008 FY | 19.85 Billion JPY | 44.1% |
| 2008 Q4 | 19.85 Billion JPY | 9.56% |
| 2008 Q3 | 18.12 Billion JPY | 0.0% |
| 2007 FY | 13.78 Billion JPY | 8.8% |
| 2006 FY | 12.66 Billion JPY | 49.94% |
| 2005 FY | 8.44 Billion JPY | -14.94% |
| 2004 FY | 9.93 Billion JPY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| DNA Chip Research Inc. | - JPY | -Infinity% |
| Cosmo Bio Company,Limited | 20 Million JPY | -131555.34% |
| H.U. Group Holdings, Inc. | 81.94 Billion JPY | 67.867% |
| FALCO HOLDINGS Co., Ltd. | 817 Million JPY | -3122.897% |
| BML, Inc. | 5.26 Billion JPY | -400.115% |
| Human Metabolome Technologies, Inc. | 226.3 Million JPY | -11535.315% |
| Precision System Science Co., Ltd. | 1.36 Billion JPY | -1826.711% |